Fresenius Medical Care AG (FMS) Long-Term Deferred Tax (2009 - 2025)

Fresenius Medical Care AG (FMS) has reported Long-Term Deferred Tax for 17 consecutive years, with $275.4 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Long-Term Deferred Tax rose 12.27% year-over-year to $275.4 million; the TTM figure through Dec 2025 stood at $275.4 million (up 12.27% YoY), while the FY2025 annual figure was $275.4 million, up 12.27% from the prior year.
• Long-Term Deferred Tax came in at $275.4 million for Q4 2025 at Fresenius Medical Care AG, up from $245.3 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $360.8 million in Q4 2021, with the low at $245.3 million in Q4 2024.
• Average Long-Term Deferred Tax over 5 years is $301.2 million, with a median of $305.5 million recorded in 2023.
• Across the five-year window, Long-Term Deferred Tax retreated 19.73% in 2024 and climbed 12.27% in 2025, its largest moves.
• Year by year, Long-Term Deferred Tax stood at $360.8 million in 2021, then slipped by 11.57% to $319.0 million in 2022, then slipped by 4.23% to $305.5 million in 2023, then slipped by 19.73% to $245.3 million in 2024, then rose by 12.27% to $275.4 million in 2025.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $275.4 million, $245.3 million, and $305.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.